Nicotinic acetylcholine receptors in the brain.
Level 5 - mechanism / opinion, no new human data
Narrative review synthesizing structural, biophysical, and neuroanatomical mechanistic evidence without systematic review methodology.
PubMed 40340066 · doi:10.1016/B978-0-443-19088-9.00004-4
What was done
The authors synthesized literature on the structural, functional, pharmacological, and cell biological characteristics of neuronal nicotinic acetylcholine receptor (nAChR) subtypes. The review describes their cellular and anatomical distribution in the brain based on findings from biochemical assays, site-directed mutagenesis, single-channel electrophysiology, and structural biophysical methods.
What was found
The abstract reports no quantitative findings or numerical data. It qualitatively outlines that nAChRs function as pentameric ligand-gated ion channels facilitating rapid synaptic transmission as well as slower intracellular signaling pathways linked to G-protein-coupled receptors, highlighting their phenotypic alterations in neurological and neuropsychiatric conditions.
Why it matters
Understanding the subtype-specific architecture, distribution, and signaling properties of brain nAChRs clarifies their physiological roles and supports rational drug targeting for neurodegenerative and neuropsychiatric disorders.
Limits
The abstract outlines a broad narrative review without systematic search protocols, risk-of-bias assessments, or quantitative data extraction. The evidence relies heavily on preclinical, in vitro, and biophysical models rather than direct clinical interventional data.
Cited by
- supports No nicotine is naturally produced in the human body; the endogenous ligand for the nicotinic acetylcholine receptor is acetylcholine.